ROLE OF ACA11, AN ORPHAN SMALL NUCLEOLAR RNA IN RESISTANCE TO CANCER CHEMOTHERAPY
孤儿小核仁 RNA ACA11 在抵抗癌症化疗中的作用
基本信息
- 批准号:8477547
- 负责人:
- 金额:$ 31.54万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-05-01 至 2018-04-30
- 项目状态:已结题
- 来源:
- 关键词:4p16.3AntibodiesB-LymphocytesBindingBiochemicalBiologicalBiological AssayBoxingCell Cycle InhibitionCell DeathCell LineCell NucleolusCell SurvivalCellsChemotherapy-Oncologic ProcedureChromosomal translocationChromosomesChromosomes, Human, Pair 4ClinicalComplementary DNAComplexCustomDataDevelopmentDiagnosisDiseaseEtiologyFunctional RNAGenesGoalsGrantGrowthGuide RNAHealthImmunologic TechniquesIntronsLaboratoriesMalignant NeoplasmsMediator of activation proteinModelingMolecularMorphologyMultiple MyelomaMusNuclear ExtractOncogenesOrphanOxidative StressPatientsPhenotypePlasmaProcessProductionProteinsPublishingRNARNA SplicingReactive Oxygen SpeciesResistanceRibosomal ProteinsRibosomal RNARoleSamplingSmall Nuclear RibonucleoproteinsSmall Nucleolar RNAStressSurvival RateTestingTherapeuticTranscriptTransformed Cell LineWHSC1 genebasebiological adaptation to stresscell growthcell transformationchemotherapeutic agentchemotherapydeep sequencinghistone methyltransferaseknock-downmRNA Expressionmembermutantnew therapeutic targetnoveloverexpressionresearch studyresponsetumorigenesis
项目摘要
DESCRIPTION (provided by applicant): The t(4;14) chromosomal translocation found in 20% of multiple myeloma (MM) cases leads to a shorter survival rate in an already incurable disease. The candidate oncogene overexpressed from the t(4;14) translocation, WHSC1 (MMSET), is unable to transform cells in culture or drive tumorigenesis in mice on its own. Examination of a 2 MB region around the t(4;14) breakpoint revealed the overexpression of a 125 bp orphan H/ACA class non-coding RNA, ACA11, which was confirmed to be up-regulated in t(4;14) MM cell lines and patient samples. Further preliminary studies demonstrate ACA11 localizes to the nucleolus as part of an small nuclear ribonucleoprotein (snRNP) complex. In addition, ACA11 overexpression reduces the levels of reactive oxygen species (ROS) in response to oxidative stress and increases cell survival in the presence of chemotherapeutic agents. We hypothesize that the overexpression of ACA11 in t(4;14) MM reduces ROS-induced cell death leading to the development and/or progression of MM. The ultimate goal of this proposal is to elucidate the mechanism by which ACA11 exerts its inhibitory effects on ROS-induced cell cycle inhibition and cell death in t(4;14) MM cell lines. We hypothesize that the overexpression of the ACA11 snoRNA in t(4;14) MM results in the altered splicing of specific RNA transcripts involved in the cellular response to ROS. These selected transcripts will encode either RNA or proteins critical for B-cell survival in MM. Therefore, ACA11 and its associated snRNP's will be potential novel targets for MM treatment or diagnosis. Three specific aims of the grant are proposed: Aim 1: To test the hypothesis that ACA11 must interact with snRNPs to exert its inhibition of oxidative stress induced cell death Aim 2: To test the hypothesis that ACA11 regulates ROS levels through modulating splicing of snoRNAs from ribosomal protein transcripts Aim 3: To test the hypothesis that overexpression of ACA11 leads to an inhibition of nucleolar stress-induced, p53-regulated ROS production
描述(由申请人提供):T(4; 14)在20%的多发性骨髓瘤(MM)病例中发现的染色体易位导致已经无法治愈的疾病的存活率较短。从T(4; 14)易位WHSC1(MMSET)过表达的候选癌基因无法自行转化培养细胞或驱动小鼠的肿瘤发生。对T(4; 14)断点周围2 MB区域的检查表明,125 bp的孤儿H/ACA类非编码RNA ACA11的过表达,该ACA11已确认在T(4; 14; 14; 14)mm细胞系和患者样品中上调。进一步的初步研究表明,作为小核核糖核蛋白(SNRNP)复合物的一部分,ACA11定位于核仁。此外,ACA11的过表达降低了对氧化应激的反应性氧(ROS)的水平,并在化学治疗剂的存在下增加细胞存活。我们假设t(4; 14)mm中ACA11的过表达降低了ROS诱导的细胞死亡,导致MM的发展和/或进展。该提案的最终目标是阐明ACA11对ROS诱导的细胞周期抑制作用和细胞死亡的抑制作用的机制(4; 14)mm细胞系。我们假设t(4; 14)mm中ACA11 snORNA的过表达导致涉及细胞响应ROS的特定RNA转录本的剪接改变。这些选定的转录物将编码对于MM中B细胞存活至关重要的RNA或蛋白质。因此,ACA11及其相关的SNRNP将是MM治疗或诊断的潜在新目标。 Three specific aims of the grant are proposed: Aim 1: To test the hypothesis that ACA11 must interact with snRNPs to exert its inhibition of oxidative stress induced cell death Aim 2: To test the hypothesis that ACA11 regulates ROS levels through modulating splicing of snoRNAs from ribosomal protein transcripts Aim 3: To test the hypothesis that overexpression of ACA11 leads to an inhibition of nucleolar应力诱导的P53调节的ROS产生
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MICHAEL H TOMASSON其他文献
MICHAEL H TOMASSON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MICHAEL H TOMASSON', 18)}}的其他基金
Sleep Disordered Breathing as a Targetable Risk Factor in Multiple Myeloma
睡眠呼吸障碍作为多发性骨髓瘤的目标危险因素
- 批准号:
10531893 - 财政年份:2021
- 资助金额:
$ 31.54万 - 项目类别:
MOLECULAR TARGETS OF TRANSLOCATION T(4;14) IN MULTIPLE MYELOMA PATHOGENESIS
多发性骨髓瘤发病机制中 T(4;14) 易位的分子靶点
- 批准号:
9187811 - 财政年份:2014
- 资助金额:
$ 31.54万 - 项目类别:
MOLECULAR TARGETS OF TRANSLOCATION T(4;14) IN MULTIPLE MYELOMA PATHOGENESIS
多发性骨髓瘤发病机制中 T(4;14) 易位的分子靶点
- 批准号:
8997472 - 财政年份:2014
- 资助金额:
$ 31.54万 - 项目类别:
MOLECULAR TARGETS OF TRANSLOCATION T(4;14) IN MULTIPLE MYELOMA PATHOGENESIS
多发性骨髓瘤发病机制中 T(4;14) 易位的分子靶点
- 批准号:
8630472 - 财政年份:2014
- 资助金额:
$ 31.54万 - 项目类别:
ROLE OF ACA11, AN ORPHAN SMALL NUCLEOLAR RNA IN RESISTANCE TO CANCER CHEMOTHERAPY
孤儿小核仁 RNA ACA11 在抵抗癌症化疗中的作用
- 批准号:
8656669 - 财政年份:2013
- 资助金额:
$ 31.54万 - 项目类别:
Genomics of AML: Contribution of Cytokine Signaling Pathways to Leukemogenesis
AML 基因组学:细胞因子信号通路对白血病发生的贡献
- 批准号:
8375663 - 财政年份:2012
- 资助金额:
$ 31.54万 - 项目类别:
ENVIRONMENT & GENETICS OF MONOCLONAL GAMMOPATHY OF UNCERTAIN SIGNIFICANCE (MGUS)
环境
- 批准号:
8321967 - 财政年份:2011
- 资助金额:
$ 31.54万 - 项目类别:
ENVIRONMENT & GENETICS OF MONOCLONAL GAMMOPATHY OF UNCERTAIN SIGNIFICANCE (MGUS)
环境
- 批准号:
8177842 - 财政年份:2011
- 资助金额:
$ 31.54万 - 项目类别:
EXPLORATION OF NEUROBEACHIN (NBEA)'S ROLE IN MULTIPLE MYELOMA
探索 NEUROBEACHIN (NBEA) 在多发性骨髓瘤中的作用
- 批准号:
7708330 - 财政年份:2009
- 资助金额:
$ 31.54万 - 项目类别:
Genomics of AML: Contribution of Cytokine Signaling Pathways to Leukemogenesis
AML 基因组学:细胞因子信号通路对白血病发生的贡献
- 批准号:
7465878 - 财政年份:2008
- 资助金额:
$ 31.54万 - 项目类别:
相似国自然基金
中和抗体gp42-IgG双向抑制EB病毒感染鼻咽上皮及B淋巴细胞降低鼻咽癌发病风险的前瞻性流行病学研究
- 批准号:82373655
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
鸡CD86分子介导囊素三肽促B淋巴细胞抗体合成调控机制研究
- 批准号:U2004151
- 批准年份:2020
- 资助金额:51 万元
- 项目类别:
鸡CD86分子介导囊素三肽促B淋巴细胞抗体合成调控机制研究
- 批准号:
- 批准年份:2020
- 资助金额:51 万元
- 项目类别:联合基金项目
自身抗体PR3-ANCA通过诱发血管炎症促进肝癌进展的机制研究
- 批准号:81902381
- 批准年份:2019
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
BLIMP-1在天疱疮自身抗体产生中的机制研究
- 批准号:81903210
- 批准年份:2019
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
- 批准号:
10752129 - 财政年份:2024
- 资助金额:
$ 31.54万 - 项目类别:
Strategies for next-generation flavivirus vaccine development
下一代黄病毒疫苗开发策略
- 批准号:
10751480 - 财政年份:2024
- 资助金额:
$ 31.54万 - 项目类别:
Molecular basis of glycan recognition by T and B cells
T 和 B 细胞识别聚糖的分子基础
- 批准号:
10549648 - 财政年份:2023
- 资助金额:
$ 31.54万 - 项目类别: